Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Breast cancer cell-derived EMMPRIN stimulates fibroblast MMP2 release through a phospholipase A2 and 5-lipoxygenase catalyzed pathway

Abstract

Metalloproteinases (MMP) produced by both cancer and normal stromal fibroblast cells play a critical role in the metastatic spread of tumours, however little is known of the regulation of their release. In this report we demonstrate that breast cancer cells in culture release apparently full length soluble EMMPRIN that promotes the release of pro-MMP2 from fibroblasts. The generation of MMP2 is mediated by activation of phospholipase A2 and 5-lipoxygenase. These results suggest that the production of soluble EMMPRIN, phospholipase A2 and 5-lipoxygenase activities are sites for potential therapeutic intervention.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 5
Figure 1
Figure 2
Figure 3
Figure 4
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

Zixuan Zhao, Xinyi Chen, … Hanry Yu

References

  • Balsinde J, Dennis EA . 1996 J. Biol. Chem. 271: 6758–6765

  • Bassett P, Bellocq JP, Wolf C, Stoll I, Hutin P, Limacher JM, Podhajcer OL, Chenard MP, Rio MC, Chambon P . 1990 Nature 348: 699–704

  • Berditchevski F, Chang S, Bodorova J, Hemler ME . 1997 J. Biol. Chem. 272: 29174–29180

  • Biswas C, Zhang Y, DeCastro R, Guo H, Nakamura T, Kataoka H, Nabeshima K . 1995 Cancer Res. 55: 434–439

  • Butler GS, Butler MJ, Atkinson SJ, Will H, Tamura T, van Westrum SS, Crabbe T, Clements J, d'Ortho MP, Murphy G . 1998 J. Biol. Chem. 273: 871–880

  • Caudroy S, Polette M, Tournier JM, Burlett H, Toole B, Zucker B, Birembaut P . 1999 J. Histochem. Cytochem. 47: 1575–1580

  • D'Errico A, Garbisa S, Liotta LA, Castronovo V, Stetler-Stevenson WG, Grigioni WF . 1991 Mod. Pathol. 4: 239–246

  • DeCastro R, Zhang Y, Guo HM, Kataoka H, Gordon MK, Toole BP, Biswas C . 1996 J. Invest. Dermatol. 106: 1260–1265

  • Ellis SM, Nabeshima K, Biswas C . 1989 Cancer Res. 49: 3385–3391

  • Ferry DR, Deakin M, Baddeley J, Daryanani S, Bramhall S, Anderson DA, Wakelam MJO, Doran J, Pemberton G, Young AM, Buckels J, Kerr DJ . 2000 Ann. Oncol. 11: 1165–1170

  • Guo H, Zucker S, Gordon MK, Bryan BP, Biswas C . 1997 J. Biol. Chem. 272: 24–27

  • Huang MT, Newmark HL, Frenkel K . 1997 J. Cell. Biochem. Suppl. 27 26–34

  • Kleiner DE, Stetler-Stevenson WG . 1999 Cancer Chemother. Pharmacol. 43: 42–51

  • Light DB, Mertins TM, Belongia JA, Witt CA . 1997 J. Membr. Biol. 158: 229–239

  • Lim M, Martinez T, Jablons D, Cameron R, Guo H, Toole B, Li J, Basbaum C . 1998 FEBS Letters 441: 88–92

  • Mohan R, Sivak J, Ashton P, Russo LA, Pham BQ, Kasahara N, Raizman MB, Fini ME . 2000 J. Biol. Chem. 275: 10405–10412

  • Nabeshima K, Lane WS, Biswas C . 1991 Arch. Biochem. Biophys 285: 90–96

  • Nomura H, Sato H, Seiki M, Mai M, Okada Y . 1995 Cancer Res. 55: 3263–3266

  • Sternlicht MD, Lochter A, Sympson CJ, Juey B, Rougier JP, Gray JW, Pinkel D, Bissell MJ, Werb Z . 1999 Cell 98: 137–146

  • Sun JX, Hemler ME . 2001 Cancer Res. 61: 2276–2281

  • Ward RV, Atkinson SJ, Reynolds JJ, Murphy G . 1994 Biochem. J. 304: 263–269

  • Winstead MV, Balsinde J, Dennis EA . 2000 Biochim. Biophys. Acta 1488: 28–39

  • Zeng ZS, Cohen AM, Guillem JG . 1999 Carcinogenesis 20: 749–755

  • Zucker S, Hymowitz M, Rollo EE, Mann R, Conner CE, Cao J, Foda HD, Tompkins DC, Toole BP . 2001 Am. J. Pathol. 158: 1921–1928

Download references

Acknowledgements

This work was supported by Cancer Research UK and The Wellcome Trust, MN Hodgkin was a Beit Memorial Research Fellow.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Michael JO Wakelam.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Taylor, P., Woodfield, R., Hodgkin, M. et al. Breast cancer cell-derived EMMPRIN stimulates fibroblast MMP2 release through a phospholipase A2 and 5-lipoxygenase catalyzed pathway. Oncogene 21, 5765–5772 (2002). https://doi.org/10.1038/sj.onc.1205702

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205702

Keywords

This article is cited by

Search

Quick links